Related Experiment Video
Updated: Sep 9, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Omega-3 Fatty Acids Supplementation and Neuroprotection, Inflammation, Fatigue, and Physical Activity in Multiple
Sahar Golabi1, Tahereh Robahat2, Nastaran Madjdinasab3
1Department of Medical Physiology, School of Medicine Abadan University of Medical Sciences Abadan Iran.
Omega-3 fatty acid supplementation did not significantly impact brain-derived neurotrophic factor (BDNF), C-reactive protein (hs-CRP), fatigue, or physical activity in multiple sclerosis (MS) patients. A potential gender-specific anti-inflammatory effect of omega-3s warrants further research.
Area of Science:
- Neuroscience and Neurology
- Nutritional Science
- Immunology
Background:
- Omega-3 fatty acids are known for their neuroprotective properties.
- Multiple sclerosis (MS) is a chronic neurological disease characterized by inflammation and neurodegeneration.
- Understanding the impact of nutritional interventions like omega-3 supplementation is crucial for managing MS symptoms.
Purpose of the Study:
- To investigate the effect of omega-3 fatty acid supplementation on serum levels of brain-derived neurotrophic factor (BDNF) and high-sensitivity C-reactive protein (hs-CRP) in MS patients.
- To assess the influence of omega-3 supplementation on physical activity and chronic fatigue in individuals with MS.
- To explore potential gender-specific responses to omega-3 supplementation in MS.
Main Methods:
- A 12-week, double-blind, placebo-controlled trial involving 68 MS patients.
- Intervention group received 1000 mg omega-3 fatty acid soft gels twice daily; control group received paraffin soft gels.
- Serum BDNF and hs-CRP levels, physical activity, and chronic fatigue were measured before and after the intervention.
Main Results:
- Both groups showed significant increases in BDNF levels post-intervention, with no significant difference between groups.
- Omega-3 supplementation did not significantly alter serum BDNF or hs-CRP levels compared to placebo.
- No significant differences in physical activity or chronic fatigue were observed between the omega-3 and placebo groups.
Conclusions:
- Omega-3 fatty acid supplementation demonstrated no significant effect on BDNF, hs-CRP, fatigue, or physical activity in MS patients.
- A notable increase in hs-CRP changes was observed in female patients compared to males, suggesting a potential gender-specific anti-inflammatory effect.
- Further research is warranted to explore the sex-related anti-inflammatory mechanisms of omega-3 fatty acids in the context of MS.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

